complex atypical hyperplasia
Showing 1 - 25 of 7,430
Complex Atypical Hyperplasia, Endometrial Cancer Trial in Chapel Hill, Cincinnati (Metformin)
Recruiting
- Complex Atypical Hyperplasia
- Endometrial Cancer
-
Chapel Hill, North Carolina
- +1 more
Jan 18, 2023
Complex Atypical Hyperplasia, Endometrial Cancer Trial in Chapel Hill (18F-fluorofuranylnorprogesterone PET / MRI)
Not yet recruiting
- Complex Atypical Hyperplasia
- Endometrial Cancer
- 18F-fluorofuranylnorprogesterone PET / MRI
-
Chapel Hill, North CarolinaUniversity of North Carolina at Chapel Hill
Jul 28, 2022
Atypical Endometrial Hyperplasia, FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma, FIGO Grade 2 Endometrial Endometrioid
Recruiting
- Atypical Endometrial Hyperplasia
- +2 more
- Everolimus
- +2 more
-
Greeley, Colorado
- +17 more
Jun 13, 2022
Atypical Endometrial Hyperplasia and Endometrial Carcinoma Stage I Trial in Beijing (statins (oral atorvastatin calcium tablet
Recruiting
- Atypical Endometrial Hyperplasia and Endometrial Carcinoma Stage I
- statins (oral atorvastatin calcium tablet 20mg/ day; Or rosuvastatin 5mg/ day; Or pivastatin 2mg/ day);
-
Beijing, Beijing, ChinaPeking University People's Hospital
Oct 22, 2023
Atypical Endometrial Hyperplasia, Endometrial Carcinoma Stage I Trial in Peking (Medroxyprogesterone acetate + Atorvastatin)
Recruiting
- Atypical Endometrial Hyperplasia
- Endometrial Carcinoma Stage I
- Medroxyprogesterone acetate + Atorvastatin
-
Peking, Beijing, ChinaWang Jianliu
Dec 29, 2022
Molecular Analysis of the Sloane Project
Enrolling by invitation
- DCIS
- +3 more
-
London, United KingdomKing's College London
May 11, 2023
Atypical Endometrial Hyperplasia, Fertility Issues, Overweight and Obesity Trial in Shanghai (Intensive Lifestyle Intervention
Recruiting
- Atypical Endometrial Hyperplasia
- +2 more
- Intensive Lifestyle Intervention (ILI)
- +2 more
-
Shanghai, ChinaObstetrics and Gynecology Hospital of Fudan University
Jun 17, 2022
Atypical Ductal Hyperplasia, Ductal Carcinoma in Situ Trial in Milan (Vacuum-assisted excisional biopsy)
Recruiting
- Atypical Ductal Hyperplasia
- Ductal Carcinoma in Situ
- Vacuum-assisted excisional biopsy
-
Milan, ItalyBreast Imaging Division, Radiology Department, IEO European Inst
Jun 27, 2023
Atypical Endometrial Hyperplasia, Obesity, Fertility Issues Trial in Shanghai (levonorgestrel-releasing intrauterine system,
Recruiting
- Atypical Endometrial Hyperplasia
- +2 more
- levonorgestrel-releasing intrauterine system
- Polyethylene Glycol Loxenatide
-
Shanghai, Shanghai, ChinaObstetrics & Gynecology Hospital of Fudan University
Jan 14, 2022
Endometrial Tumors, Atypical Endometrial Hyperplasia, Progesterone Resistance Trial in Shanghai (GnRHa, Letrozole 2.5mg,
Recruiting
- Endometrial Neoplasms
- +2 more
- GnRHa
- +3 more
-
Shanghai, Shanghai, ChinaObstetrics and Gynecology Hospital, Fudan University
Jul 29, 2022
Endometrial Hyperplasia Trial in Winston-Salem (Megestrol Acetate, Levonorgestrel Drug Implant)
Recruiting
- Endometrial Hyperplasia
- Megestrol Acetate
- Levonorgestrel Drug Implant
-
Winston-Salem, North CarolinaWake Forest Baptist Health Sciences
Aug 5, 2022
Atypical Hyperplasia, Lobular Carcinoma in Situ Trial in Rochester (Tamoxifen, Topical 4-OHT( 4-hydroxytamoxifen)gel 2 mg/each
Recruiting
- Atypical Hyperplasia
- Lobular Carcinoma in Situ
- Tamoxifen
- +2 more
-
Evanston, Illinois
- +1 more
Jan 20, 2023
Atypical Endometrial Hyperplasia Trial in Shanghai (Metformin plus Megestrol acetate, Megestrol Acetate)
Terminated
- Atypical Endometrial Hyperplasia
- Metformin plus Megestrol acetate
- Megestrol Acetate
-
Shanghai, Shanghai, ChinaObstetrics and Gynecology Hospital, Fudan University
Mar 24, 2022
Atypical Endometrial Hyperplasia Trial in Shanghai (Megestrol Acetate, Rosuvastatin)
Recruiting
- Atypical Endometrial Hyperplasia
- Megestrol Acetate
- Rosuvastatin
-
Shanghai, ChinaObstetrics and Gynecology Hospital, Fudan University
Aug 17, 2021
Endometrial Cancer, Atypical Endometrial Hyperplasia Trial in Chengdu (Progesterone, Mirena®, GnRH agonist)
Recruiting
- Endometrial Cancer
- Atypical Endometrial Hyperplasia
- Progesterone
- +2 more
-
Chengdu, Sichuan, ChinaWest China Second University Hospital
Sep 3, 2021
Endometrial Atypical Hyperplasia, Endometrial Adenocarcinoma Trial in Shanghai, Hangzhou (Megestrol acetate and metformin,
Completed
- Endometrial Atypical Hyperplasia
- Endometrial Adenocarcinoma
- Megestrol acetate and metformin
- Megestrol acetate
-
Shanghai, Shanghai, China
- +4 more
Sep 10, 2021
Fertility Sparing Trial in Beijing (Medroxyprogesterone Acetate 500 MG Oral Tablet, Levonorgestrel-Releasing Intrauterine
Recruiting
- Fertility Sparing
- Medroxyprogesterone Acetate 500 MG Oral Tablet
- Levonorgestrel-Releasing Intrauterine System
-
Beijing, Beijing, ChinaBei Jing Chao-Yang Hospital
Oct 3, 2022
Atypical Endometrial Hyperplasia, Endometrial Carcinoma Trial in Duarte (Megestrol Acetate, Pterostilbene)
Recruiting
- Atypical Endometrial Hyperplasia
- Endometrial Carcinoma
- Megestrol Acetate
- Pterostilbene
-
Duarte, CaliforniaCity of Hope Medical Center
Oct 12, 2022
Standard Breast Cancer Risk Assessment for African American and
Not yet recruiting
- Breast Atypical Ductal Hyperplasia
- +3 more
- Biospecimen Collection
- +2 more
-
Jacksonville, FloridaMayo Clinic in Florida
Feb 22, 2023
Anorexia Nervosa, Atypical Anorexia Nervosa (Other Specified Eating Disorder), Bulimia Nervosa Trial (GST, CBT-E)
Not yet recruiting
- Anorexia Nervosa
- +3 more
- GST
- CBT-E
- (no location specified)
Apr 13, 2023
Endometrial Carcinoma Stage I, Atypical Endometrial Hyperplasia Trial (No intervention)
Not yet recruiting
- Endometrial Carcinoma Stage I
- Atypical Endometrial Hyperplasia
- No intervention
- (no location specified)
Dec 3, 2022
Breast Atypical Ductal Hyperplasia, Breast Atypical Lobular Hyperplasia, Breast Ductal Carcinoma In Situ Trial in Houston
Completed
- Breast Atypical Ductal Hyperplasia
- +4 more
- Bexarotene
- Questionnaire Administration
-
Houston, TexasM D Anderson Cancer Center
Dec 13, 2022
Atypical Endometrial Hyperplasia, Obese, Fertility Issues Trial (Liraglutide Injection, Megestrol Acetate 160 MG)
Withdrawn
- Atypical Endometrial Hyperplasia
- +2 more
- Liraglutide Injection
- Megestrol Acetate 160 MG
- (no location specified)
Mar 23, 2021